NewEdge Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
+20,280
New +$196K ﹤0.01% 2500
2025
Q1
Sell
-18,622
Closed -$307K 4062
2024
Q4
$307K Buy
18,622
+2,558
+16% +$39.7K ﹤0.01% 1863
2024
Q3
$237K Buy
16,064
+10,634
+196% +$166K ﹤0.01% 1927
2024
Q2
$75.3K Buy
5,430
+534
+11% +$7.57K ﹤0.01% 2201
2024
Q1
$77K Buy
4,896
+1,711
+54% +$26.4K ﹤0.01% 2152
2023
Q4
$51.5K Buy
3,185
+340
+12% +$5.56K ﹤0.01% 2220
2023
Q3
$35K Sell
2,845
-288
-9% -$4.28K ﹤0.01% 2211
2023
Q2
$50.3K Buy
+3,133
New +$51.6K ﹤0.01% 2083
2023
Q1
Sell
-157
Closed -$1.45K 3885
2022
Q4
$1.45K Buy
+157
New +$1.46K ﹤0.01% 2922
2021
Q4
Sell
-10,310
Closed -$497K 1678
2021
Q3
$497K Buy
10,310
+736
+8% +$34.1K 0.01% 748
2021
Q2
$433K Buy
+9,574
New +$424K 0.01% 780

Other funds holding NEO

NewEdge Advisors's NEO Position: Q2 2026 in Review

NewEdge Advisors opened a new position in NeoGenomics (NEO) in Q2 2026: 20,280 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #2500 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in NEO as recently as Q4 2024.

NewEdge Advisors first reported a position in NEO in Q2 2021 and has held it in 11 quarters since. The position peaked at $497K in Q3 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • NewEdge Advisors held 20,280 shares of NeoGenomics worth $296K as of Q2 2026.
  • NeoGenomics was a new NewEdge Advisors position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2500 holding.
  • NewEdge Advisors first reported a position in NeoGenomics in Q2 2021 and has held it in 11 quarters since.
  • NewEdge Advisors's NeoGenomics position peaked at $497K in Q3 2021.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.